News
Trial finds Lilly’s Olumiant could treat type 1 diabetes
Treatment with Eli Lilly’s JAK inhibitor Olumiant has been shown to preserve the function of insulin-producing pancreatic beta cells in patients with type 1 diabetes, pote
